Mmastodon ScienceScience first seen 4 d ago, last 4 d ago, peak #4

Anthropic's Claude fails to design scorpion antivenom in AI drug test

Original: An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to

An investment research firm partnered with Anthropic to test whether an unreleased version of Claude could develop scorpion antivenom, aiming to demonstrate AI's potential in drug development. The model produced some promising starting points but could not create a viable treatment, tempering claims that AI is close to revolutionizing pharmaceutical research.

Why now: The result challenges hype about AI rapidly transforming drug discovery.

AnthropicClaude

Open on mastodon →

Evidence

• An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up with some promising starting points, but nothing close to… · verge@www.urbanmind.net · 3

API: https://socialmediatrends-api.osmike.com/v1/trends/3247278